Human medicines
Locabiosol
The marketing authorization holder has informed its supplied customers in a letter dated 20.04.2016 that the marketing authorizations of medicinal…
Clustoid
The marketing authorization holder has informed its supplied customers in a letter dated April 15, 2016, that a possible non-sterility cannot be…
Curatoderm
In a letter dated April 13, 2016, the marketing authorization holder informed its customers that the above-mentioned batch of "Curatoderm - Ointment"…
Noradrenalin
The pharmaceutical company "Amomed Pharma GmbH" has informed its supplied customers by letter dated 11.03.2016 that in the course of stability testing…
Ultracortenol eye drops
Agepha Pharma has informed its customers in a letter dated 24.02.2016 about the recall of the mentioned batch for the following reason: The…
Aqua ad injectionem
The company B. Braun Austria Ges.m.b.H. informed its supplied customers in a letter dated 28.01.2016 that due to customer complaints about leaking…
Alprostapint
The marketing authorization holder informed its supplied customers in a letter dated December 16, 2015, that a reduced active ingredient content was…
Alustal, Phostal, Staloral
The marketing authorization holder and its distribution partner informed the supplied customers in a letter dated 14.12.2015 that after the…
Gabapentin
The marketing authorization holder informed its supplied customers in a letter dated December 4, 2015, that a precautionary recall of the batch R09199…
Propofol
The marketing authorization holder has informed its supplied customers in a letter dated 17.11.2015 that the above mentioned batch has a blue instead…
